Try our beta test site
1 study found for:    15947928 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Biological: Opioid Growth Factor (OGF)

Study has passed its completion date and status has not been verified in more than two years.